Kuros Biosciences AG (LON:0RHR)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	769	120	48	51	55	43
Market Cap Growth	762.84%	148.06%	-5.72%	-6.74%	27.87%	55.53%
Enterprise Value	758	107	31	31	44	35
Last Close Price	20.15	3.25	1.35	1.62	1.71	1.72
PS Ratio	8.36	3.82	2.99	4.57	16.40	21.48
PB Ratio	7.30	2.26	0.78	0.82	0.78	0.71
P/TBV Ratio	22.80	8.15	2.67	3.01	2.45	3.42
EV/Sales Ratio	16.40	3.41	1.90	2.77	13.27	17.71
Debt / Equity Ratio	0.03	0.04	0.03	0.03	0.03	0.03
Asset Turnover	0.68	0.43	0.21	0.15	0.04	0.03
Inventory Turnover	1.14	1.27	1.47	2.33	1.96	2.96
Quick Ratio	2.08	1.66	2.20	2.72	7.69	6.01
Current Ratio	2.73	2.06	2.49	2.91	8.76	6.40
Return on Equity (ROE)	-14.32%	-21.86%	-20.02%	-9.33%	-14.18%	-14.58%
Return on Assets (ROA)	-3.77%	-7.01%	-7.06%	-5.90%	-8.09%	-8.20%
Return on Capital (ROIC)	-4.54%	-8.34%	-8.20%	-6.59%	-8.81%	-9.08%
Earnings Yield	-1.02%	-10.70%	-27.17%	-11.95%	-17.39%	-20.45%
FCF Yield	-0.37%	-7.14%	-14.41%	-9.13%	-14.04%	-19.88%
Buyback Yield / Dilution	17.17%	-7.91%	-3.37%	-34.86%	-53.69%	-81.36%
Total Shareholder Return	17.17%	-7.91%	-3.37%	-34.86%	-53.69%	-81.36%

Source: S&P Capital IQ. Standard template. Financial Sources.